DSIP
- Category
- Specialized Research
- Administration routes
- Injectable
- Regulatory status
- Not FDA-approved
What it is
A synthetic nine-amino-acid peptide marketed to promote deep, delta-wave sleep, with secondary claims for stress, pain, and hormone balance. The evidence is thin: small human studies suggest a modest sleep benefit, while the other uses rest on animal and mechanism data. There is no long-term clinical safety data, and, unusually, no receptor or gene for it has been identified. Not an approved drug in the US, and most supply is unregulated research-grade.
Read Full recordStudied uses & evidence
Studied uses(7)
Sleep quality improvement
MediumA small double-blind trial found modestly shorter sleep latency, though effects were weak and unreplicated.
Stress response modulation
LowAnimal data suggest HPA-axis calming, but human results are mixed with no clinical trial.
Pain reduction
LowStrong rodent painkilling data, but human evidence is one small uncontrolled 1984 pilot.
Evidence limits
- Evidence Level
- Preliminary
Clinical evidence for DSIP spans several small human trials (typically 7-16 subjects) conducted primarily in the 1980s-1990s, with contradictory results for sleep promotion. Withdrawal and pain findings are also preliminary, relying largely on uncontrolled studies. No large-scale randomized controlled trials have been conducted. The peptide's gene, receptor, and precursor remain unidentified, limiting mechanistic understanding.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
Do not use if
Epilepsy
ModerateDSIP modulates GABA and sleep-wake neurotransmission. May interact unpredictably with seizure thresholds.
General cautions
Pregnancy
AbsoluteNo safety data.
Risk summary(6)
Risks = level of concern: High · Moderate · Low · Theoretical
Long-term safety has not been established in any clinical research study
HighVery short in vitro half-life (~15 minutes) raises bioavailability questions
LowNo identified gene, receptor, or precursor protein; mechanism incompletely understood
ModerateHeadaches, dizziness, GI issues reported anecdotally
LowFatigue or excessive lethargy if dose too high or timing wrong
LowInjection site reactions including redness and mild irritation
Low
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.